American International Group, Inc. Summit Therapeutics Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.55 - $5.07 $1,249 - $2,484	-490 Reduced 0.85%	57,108 $236,000
Q4 2023 Feb 13, 2024	SELL	$1.67 - $2.83 $389 - $659	-233 Reduced 0.4%	57,598 $150,000
Q3 2023 Nov 13, 2023	BUY	$1.54 - $2.42 $3,166 - $4,975	2,056 Added 3.69%	57,831 $108,000
Q2 2023 Aug 04, 2023	BUY	$1.32 - $2.81 $73,623 - $156,727	55,775 New	55,775 $139,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.38 $12,040 - $31,147	-13,087 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.0 - $3.45 $1,840 - $3,174	-920 Reduced 6.57%	13,087 $32,000
Q4 2021 Feb 11, 2022	SELL	$2.45 - $5.64 $1,026 - $2,363	-419 Reduced 2.9%	14,007 $38,000
Q3 2021 Nov 12, 2021	BUY	$4.83 - $8.27 $8,843 - $15,142	1,831 Added 14.54%	14,426 $72,000
Q2 2021 Aug 13, 2021	BUY	$5.15 - $8.46 $64,864 - $106,553	12,595 New	12,595 $94,000

138

64.4M

1.06M

1.02M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.41B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.